Budesonide
CB-01-02/06
Phase 3 small_molecule completed
Quick answer
Budesonide for Colitis, Ulcerative is a Phase 3 program (small_molecule) at Bausch + Lomb Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bausch + Lomb Ireland Limited
- Indication
- Colitis, Ulcerative
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed